Insulinoma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Insulinoma}} | {{Insulinoma}} | ||
{{CMG}}{{AE}}{{ | {{CMG}}{{AE}}{{ADS}} | ||
==Overview== | ==Overview== | ||
| Line 11: | Line 11: | ||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
* | *Somatostatin receptor scintigraphy(SRS) may be helpful in the diagnosis of pancreatic neuroendocrine tumors including insulinomas. As a majority of insulinomas does not express somatostatin receptors, it is less accurate. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include: | ||
**[finding 1] | **[finding 1] | ||
**[finding 2] | **[finding 2] | ||
Revision as of 12:42, 31 August 2017
|
Insulinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Insulinoma other imaging findings On the Web |
|
American Roentgen Ray Society Images of Insulinoma other imaging findings |
|
Risk calculators and risk factors for Insulinoma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
There are no other imaging findings associated with [disease name].
OR
[Imaging modality] may be helpful in the diagnosis of [disease name]. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
Other Imaging Findings
- Somatostatin receptor scintigraphy(SRS) may be helpful in the diagnosis of pancreatic neuroendocrine tumors including insulinomas. As a majority of insulinomas does not express somatostatin receptors, it is less accurate. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include:
- [finding 1]
- [finding 2]
- [finding 3]